FRED B CRAVES
CIK 1014095 · last filed 2025-03-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$197.80M
Companies
5
Total Filings
70
Lifetime Open-Market Net
-$217.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Director | 352,779 | $538.71 | $190.05M | -$220.59M | 26 | 2025-03-14 |
| TWST | Director | 58,168 | $132.06 | $7.68M | $0 | 2 | 2019-10-09 |
| DERM | Director | 9,000 | $7.57 | $68.1K | $1.80M | 8 | 2019-06-14 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 635,739 | — | — | $1.00M | 21 | 2011-06-10 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Director | — | — | — | $0 | 1 | 2009-03-16 |
Recent Filings · Page 6 of 7
70 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-06-25 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-03-30 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +5,000 | $10.7K | EDGAR |
| 2009-03-30 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +15,000 | $31.5K | EDGAR |
| 2009-03-16 | VIA Pharmaceuticals, Inc. (VIAP) Delisted | Buy (P) | — | $0 | EDGAR |
| 2008-12-23 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +2,900 | $5.1K | EDGAR |
| 2008-12-23 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +25,000 | $43.8K | EDGAR |
| 2008-12-19 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +26,500 | $50.3K | EDGAR |
| 2008-12-17 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +13,000 | $24.9K | EDGAR |
| 2008-12-17 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +11,900 | $23.3K | EDGAR |
| 2008-06-25 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.